New potential therapeutic target identified for Diffuse Large B-Cell Lymphoma
Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have discovered a new potential therapeutic target for Diffuse Large B-Cell Lymphoma (DLBCL), the most aggressive and ...
Nov 28, 2011
0
0